Strikingly, when Plk1 inducible expression in mammary glands was combined with mice strains carrying either the K-Ras or Her2 oncogenes, tumor incidence was dramatically reduced in both cases, up to 85% and 50%, respectively (Figure 2b). This evidence concerns the gene KRAS and neoplasm.